This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Anthony S. Fauci, MD

JAMA. 1996;276(2):155-156.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

On July 7 through 12,1996, the 11th International Conference on AIDS (acquired immunodeficiency syndrome) will take place in Vancouver, British Columbia. Unlike the pessimism that prevailed during the 9th International Conference in Berlin in 1993 and, to a lesser extent, the 10th International Conference in Yokohama in 1994, the general feeling among planned participants is one of cautious optimism. One of the reasons for this swing toward optimism is the fact that a number of recent research advances have led to a greater understanding of the pathogenic mechanisms of human immunodeficiency virus (HIV) disease and form the basis for therapeutic and vaccine strategies. A few of these deserve particular attention since they reflect a convergence of greater understanding of both viral and host factors and have practical, and even immediate, implications for the care of HIV-infected individuals.

It had been previously demonstrated that HIV actively replicates in lymphoid tissue^1,2 . . . [Full Text PDF of this Article]

Author Affiliations
From the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.

Footnotes
Reprints: Anthony S. Fauci, MD, NIAID/National Institutes of Health, Bldg 31, Room 7A03, MSC 2520, Bethesda, MD 20892-2520.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?